Innovent Biologics senior vice-president Dr Zhou Hui said: “I’m pleased that the Phase III clinical study of IBI354 in HER2-expressing PROC has completed the first participant dosing.

China's armed forces have become a key factor and a vital force in United Nations (UN) peacekeeping efforts, experts ...